Inventor · disambiguated record
Michael Dore
Also filed as: DORE MICHAEL
12 granted patents·5 pending applications·53 citations·filing 2015–2024
89Inventor score
Top patents by PatentIndex Score
17 records- 0194US12139488B2Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative diseaseUNIV MONTREAL·Filed 2024·Granted Nov 12, 2024·2 cites·22 claims
- 0292US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0392US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0490US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0590US9815813B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2015·Granted Nov 14, 2017·13 cites·8 claims
- 0689US12060353B2Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative diseaseUNIV MONTREAL·Filed 2023·Granted Aug 13, 2024·3 cites·29 claims
- 0788US10301278B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted May 28, 2019·8 cites·7 claims
- 0888US2025270207A1Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative diseaseUNIV MONTREAL·Filed 2024·Application pending·0 cites
- 0981US10975080B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·3 claims
- 1077US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1176US12479842B2Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative diseaseUNIV MONTREAL·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 1275US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 1374US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 1466US2021309663A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1565US2022089597A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1657US2024239801A1Pyrimido[5,4,d]pyrimidine compounds, compositions comprising them and uses thereofUNIV MONTREAL·Filed 2022·Application pending·0 cites
- 1751US12473273B2Quinoline compounds and compositions for inhibiting EZH2NOVARTIS AG·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Michael Dore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →